NCM
DCPH

Nantahala Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Nantahala Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-38,247
Closed -$1.3M – 94
2019
Q3 		$1.3M Buy
+38,247
New +$1.13M 0.05% 87

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nantahala Capital Management's DCPH Position: Q4 2019 in Review

Nantahala Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2019, closing a stake of 38,247 shares — an estimated $1.3M sold.

Nantahala Capital Management first reported a position in DCPH in Q3 2019 and held it in 1 quarter. The position peaked at $1.3M in Q3 2019. 153 funds tracked by Wall St. Rank hold DCPH as of Q4 2019.

  • Nantahala Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Nantahala Capital Management sold 38,247 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.3M.
  • Nantahala Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Nantahala Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.3M in Q3 2019.
  • 153 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Nantahala Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.